It is the first membrane-permeable, selective inhibitor of nicotinamide N-methyltransferase (NNMT), developed at the University of Texas in 2017
Semaglutide is an approved GLP-1 receptor agonist with well-known side effects and monitoring guidelines, whereas AOD-9604 does not have the same approval or long-term safety information
Dietary management becomes essential on tirzepatide, not optional
Signs of Vitamin B12 deficiency may include abnormal pain, confusion, constipation, depression, diarrhea, fatigue, gas, loss of appetite, numbness, weight loss, and etc
In the UK, hydroxocobalamin is the preferred licensed form for intramuscular injection
The frequency of injections varies based on the treatment